Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-30

Clinical Trial Update: β-galactosidase Producing Probiotic Strains to Improve Lactose Digestion [NA]

View source ↗

Summary

Nestlé's SPN completed a clinical trial evaluating beta-galactosidase-producing probiotic strains to improve lactose digestion in people with lactose intoleranc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Beta-galactosidase-producing probiotic strains (Nestlé SPN) (beta-galactosidase-producing probiotic strains)

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Lactose Intolerance | NA | Status: COMPLETED